Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hishiki

Showing results (371-380 of 399) with videos related to

Pageof 40
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2020
Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 ProtocolEiso Hiyama, Tomoro Hishiki, Kenichiro Watanabe, et al.
Pediatric Blood & Cancer|May 10, 2025
Treatment of Intermediate-Risk Hepatoblastoma Using a Combined Cisplatin and Doxorubicin (PLADO) Regimen and Optimized Surgical ResectionTomoro Hishiki, Kohmei Ida, Kenichiro Watanabe, et al.
The Journal of Infectious Diseases|March 9, 2023
Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as TreatmentsDaisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki, et al.
Cardiovascular Endocrinology & Metabolism|October 2, 2023
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonistsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
European Journal of Human Genetics : EJHG|March 29, 2020
High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumorsRyota Shirai, Tomoo Osumi, Keita Terashima, et al.
Cancers|January 30, 2020
Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular CarcinomaMakoto Chuma, Haruki Uojima, Kazushi Numata, et al.
Diabetes Research and Clinical Practice|February 8, 2022
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonistsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
Pediatric Blood & Cancer|August 10, 2024
Successful treatment of young childhood standard-risk hepatoblastoma with cisplatin monotherapy using a central review systemIsamu Saeki, Kohmei Ida, Sho Kurihara, et al.
The Pediatric Infectious Disease Journal|February 2, 2023
Acute and Postacute Clinical Characteristics of Coronavirus Disease 2019 in Children in JapanTomohiro Katsuta, Yuta Aizawa, Kensuke Shoji, et al.
Nature Microbiology|April 17, 2019
Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA virusesDaisuke Yamane, Hui Feng, Efraín E Rivera-Serrano, et al.
Pageof 40

Showing results (371-380 of 399) with videos related to

Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2020
Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 ProtocolEiso Hiyama, Tomoro Hishiki, Kenichiro Watanabe, et al.
Pediatric Blood & Cancer|May 10, 2025
Treatment of Intermediate-Risk Hepatoblastoma Using a Combined Cisplatin and Doxorubicin (PLADO) Regimen and Optimized Surgical ResectionTomoro Hishiki, Kohmei Ida, Kenichiro Watanabe, et al.
The Journal of Infectious Diseases|March 9, 2023
Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as TreatmentsDaisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki, et al.
Cardiovascular Endocrinology & Metabolism|October 2, 2023
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonistsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
European Journal of Human Genetics : EJHG|March 29, 2020
High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumorsRyota Shirai, Tomoo Osumi, Keita Terashima, et al.
Cancers|January 30, 2020
Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular CarcinomaMakoto Chuma, Haruki Uojima, Kazushi Numata, et al.
Diabetes Research and Clinical Practice|February 8, 2022
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonistsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
Pediatric Blood & Cancer|August 10, 2024
Successful treatment of young childhood standard-risk hepatoblastoma with cisplatin monotherapy using a central review systemIsamu Saeki, Kohmei Ida, Sho Kurihara, et al.
The Pediatric Infectious Disease Journal|February 2, 2023
Acute and Postacute Clinical Characteristics of Coronavirus Disease 2019 in Children in JapanTomohiro Katsuta, Yuta Aizawa, Kensuke Shoji, et al.
Nature Microbiology|April 17, 2019
Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA virusesDaisuke Yamane, Hui Feng, Efraín E Rivera-Serrano, et al.
Pageof 40